Anpario (LON:ANP) Hits New 12-Month High – Should You Buy?

Shares of Anpario plc (LON:ANP) hit a new 52-week high during trading on Tuesday . The stock traded as high as GBX 474 ($6.01) and last traded at GBX 474 ($6.01), with a volume of 110170 shares trading hands. The stock had previously closed at GBX 452.50 ($5.73).

Analyst Upgrades and Downgrades

Separately, Canaccord Genuity Group increased their price objective on shares of Anpario from GBX 380 ($4.82) to GBX 500 ($6.34) and gave the company a “buy” rating in a research report on Tuesday, January 14th.

Anpario Stock Up 1.1 %

The company’s 50-day moving average is GBX 416.42 and its 200 day moving average is GBX 347.93. The company has a market capitalization of £79.76 million, a PE ratio of 25.82 and a beta of 0.58. The company has a debt-to-equity ratio of 0.10, a quick ratio of 5.16 and a current ratio of 6.15.

Insider Activity at Anpario

In other Anpario news, insider Karen Prior sold 14,000 shares of the company’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.82), for a total transaction of £53,200 ($67,410.04). 30.51% of the stock is currently owned by insiders.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.